The Cytotoxicity Test is designed to evaluate the general toxicity of medical devices and materials. Testing involves extracting devices in a cell culture media and then exposing the extract fluid to mouse fibroblast cells.
The global Cytotoxicity Testing market size is projected to grow from US$ 12520 million in 2023 to US$ 22470 million in 2030; it is expected to grow at a CAGR of 8.7% from 2024 to 2030.
This Insight Report provides a comprehensive analysis of the global Cytotoxicity Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity.
The future of the cytotoxicity testing market is optimistic, driven by the increasing demand for safe and effective drugs, medical devices, and consumer products, stringent regulatory requirements, and ongoing technological advancements.
Segmentation by type
- Elution Testing Method
- Agar Overlay Method
- Direct Contact Method
- MTT Assay Method
- Others
Segmentation by application
- Medical Device
- Medical Accessories
- Others
Market by region
- Americas
- APAC
- Europe
- Middle East & Africa
Company's coverage
- Sartorius
- UL
- Eurofins
- SGS
- Emery Pharma
- Nelson Labs
- UFAG Laboratorien AG
- Pacific BioLabs
- NorthEast BioLab
- Biosafe Ltd
- Creative Bioarray
- Evercyte
- IONTOX
- Applied StemCell
- Xenometrix AG
- TÜV SÜD
- Medicilon
- Huatongwei
Key Questions Addressed in this Report
Frequently Asked Questions
What is the USP of the report? expand_more
What are the key content of the report? expand_more
- Global Market Players
- Geopolitical regions
- Consumer Insights
- Technological advancement
- Historic and Future Analysis of the Market